HHSC updated the respiratory syncytial virus (RSV) season schedule to end the interseasonal RSV season on September 30, 2021.
Per the recommendations from the RSV task force and the HHSC Office of Medical Director (OMD), HHSC requires prescribing providers to reassess the need for RSV prophylaxis beginning October 1, 2021, and submit a new Syangis prior authorization request. A new prior authorization is required for clients who continue to meet the criteria for treatment with Synagis during the traditional season.
The prior authorization criteria and the policy for processing those prior authorization forms will remain unchanged. HHSC, in partnership with the RSV task force and the OMD, will continue to monitor the situation and make recommendations throughout the season.